RASA2 and neoplasm: Further in vitro study showed that knockdown of TUC338 upregulated the expression level of RAS GTPase activating protein (RasGAP) gene RASAL1 153, which inhibits tumor progression by catalyzing RAS inactivation to negatively regulate the RAS signaling pathway 154.